Innovative Blood Hemoglobin Testing Technology to Transform Global Healthcare

WEST LAFAYETTE, Ind. - HemaChrome LLC, a digital mobile health startup backed by Purdue University, has achieved a significant breakthrough in its innovative blood hemoglobin testing technology.

HemaChrome's machine learning-based system utilizes spectroscopy and computational algorithms to measure blood hemoglobin levels from a digital photo of the inner eyelid, noninvasively and instantly. This technology will enable clinicians to conduct point-of-care, home-based, and remote diagnostic tests at a fraction of the cost traditional methods require.

According to Young Kim, HemaChrome's founder and chief science officer, the company has developed a patent-pending method that extracts true colors from a digital photo with unprecedented accuracy. This innovation is critical to the technology's success and is being collaborated on by Global Health Labs Inc., a nonprofit organization funded by Gates Ventures as an independent partner to support the Gates Foundation strategies.

The partnership aims to enhance HemaChrome's algorithms and advance the development of this life-changing technology. With GH Labs' support, HemaChrome plans to release its initial product in late 2025, with future collaborations on related projects, including color calibration technology.

HemaChrome's innovative blood hemoglobin testing technology has the potential to transform global healthcare by making it more accessible and affordable for underserved populations. According to Huiri Kim, CEO of HemaChrome, "Many people, especially those in low-resource settings, don't have access to accurate anemia testing, which can lead to devastating consequences."

Anemia affects an estimated 1.93 billion people globally, ranking as the third-leading case of disabilities worldwide. It's a global health crisis that can be prevented and treated with affordable and accessible testing.

Purdue University is supporting HemaChrome through its technology transfer programs, including licensing and commercializing technologies, and has received funding from the National Institutes of Health as part of its Technology Accelerator Challenge.

"We hope to continue our partnership with GH Labs on related projects, which we believe will transform the digital health care space," Huiri Kim said.

HemaChrome's innovative blood hemoglobin testing technology is poised to revolutionize global healthcare by making it more accessible and affordable for underserved populations.